BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2353792)

  • 1. Microvascular changes in early and advanced dermatomyositis: a quantitative study.
    Emslie-Smith AM; Engel AG
    Ann Neurol; 1990 Apr; 27(4):343-56. PubMed ID: 2353792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular deposition of complement membrane attack complex in dermatomyositis.
    Kissel JT; Mendell JR; Rammohan KW
    N Engl J Med; 1986 Feb; 314(6):329-34. PubMed ID: 3945256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis.
    Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Gulati S; Handa R
    Acta Neurol Scand; 2011 Feb; 123(2):122-9. PubMed ID: 20497129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle.
    De Visser M; Emslie-Smith AM; Engel AG
    J Neurol Sci; 1989 Dec; 94(1-3):181-92. PubMed ID: 2614466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular pathology in dermatomyositis and anatomic relations to myopathology.
    Pestronk A; Schmidt RE; Choksi R
    Muscle Nerve; 2010 Jul; 42(1):53-61. PubMed ID: 20544925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
    Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
    Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.
    Grundtman C; Tham E; Ulfgren AK; Lundberg IE
    Arthritis Rheum; 2008 Oct; 58(10):3224-38. PubMed ID: 18821695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (IIM).
    Cid MC; Grau JM; Casademont J; Tobías E; Picazo A; Coll-Vinent B; Esparza J; Pedrol E; Urbano-Márquez A
    Clin Exp Immunol; 1996 Jun; 104(3):467-73. PubMed ID: 9099932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular alterations and the role of complement in dermatomyositis.
    Lahoria R; Selcen D; Engel AG
    Brain; 2016 Jul; 139(Pt 7):1891-903. PubMed ID: 27190020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis.
    Kissel JT; Halterman RK; Rammohan KW; Mendell JR
    Arch Neurol; 1991 Jan; 48(1):26-30. PubMed ID: 1986724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrotizing myopathy with microvascular deposition of the complement membrane attack complex.
    De Bleecker J; Vervaet V; Van den Bergh P
    Clin Neuropathol; 2004; 23(2):76-9. PubMed ID: 15074581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
    Basta M; Dalakas MC
    J Clin Invest; 1994 Nov; 94(5):1729-35. PubMed ID: 7962520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ragged red fibers in normal aging and inflammatory myopathy.
    Rifai Z; Welle S; Kamp C; Thornton CA
    Ann Neurol; 1995 Jan; 37(1):24-9. PubMed ID: 7818253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis.
    Gonçalves FG; Chimelli L; Sallum AM; Marie SK; Kiss MH; Ferriani VP
    J Rheumatol; 2002 Jun; 29(6):1301-7. PubMed ID: 12064850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin deposition in skeletal muscle in primary muscle diseases.
    Isenberg DA
    Q J Med; 1983; 52(207):297-310. PubMed ID: 6647747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of capillaries in normal and diseased human skeletal muscle.
    Carry MR; Ringel SP; Starcevich JM
    Muscle Nerve; 1986 Jun; 9(5):445-54. PubMed ID: 2941685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune effector mechanisms in inflammatory myopathies.
    Engel AG; Arahata K; Emslie-Smith A
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():141-57. PubMed ID: 2158132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrosis of capillaries in denervation atrophy of human skeletal muscle.
    Carpenter S; Karpati G
    Muscle Nerve; 1982 Mar; 5(3):250-4. PubMed ID: 7088023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy.
    Estruch R; Grau JM; Fernández-Solá J; Casademont J; Monforte R; Urbano-Márquez A
    Hum Pathol; 1992 Aug; 23(8):888-95. PubMed ID: 1644434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.